Economic Burden of Metastatic Clear-Cell Renal Cell Carcinoma for French Patients Treated With Targeted Therapies-Reference-Cited by-同舟云学术

Economic Burden of Metastatic Clear-Cell Renal Cell Carcinoma for French Patients Treated With Targeted Therapies

Published:2019-02 Issue:1 Volume:17 Page:e227-e234
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Cholley Tiphaine,Thiery-Vuillemin Antoine,Limat Samuel,Hugues Marion,Calcagno Fabien,Mouillet Guillaume,Anota Amélie,Nerich Virginie

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference36 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

2. American Cancer Society. Kidney Cancer. Available at: https://www.cancer.org/cancer/kidney-cancer.html; https://uroweb.org/wp-content/uploads/10-Renal-Cell-Carcinoma_2017_web.pdf. Accessed October, 2018.

3. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial;Escudier;Lancet,2007

4. Sunitinib vs. interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

5. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scoping review of economic analyses of rare kidney diseases;Kidney International Reports;2024-09

2. Renal cell carcinoma: the population, real world, and cost-of-illness;BMC Urology;2022-12-19

3. Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspective;Journal of Medical Economics;2021-01-01

4. The Evolving Role of Metastasectomy for Patients with Metastatic Renal Cell Carcinoma;Urologic Clinics of North America;2020-08